Theralase Technologies Stock Performance
| TLTFF Stock | USD 0.22 0.01 4.35% |
On a scale of 0 to 100, Theralase Technologies holds a performance score of 11. The entity has a beta of 0.55, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Theralase Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding Theralase Technologies is expected to be smaller as well. Please check Theralase Technologies' jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Theralase Technologies' existing price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Theralase Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Theralase Technologies reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.9 M | |
| Total Cashflows From Investing Activities | -100.8 K |
Theralase |
Theralase Technologies Relative Risk vs. Return Landscape
If you would invest 14.00 in Theralase Technologies on November 14, 2025 and sell it today you would earn a total of 8.00 from holding Theralase Technologies or generate 57.14% return on investment over 90 days. Theralase Technologies is currently producing 0.9895% returns and takes up 7.0323% volatility of returns over 90 trading days. Put another way, 63% of traded otc stocks are less volatile than Theralase, and 81% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Theralase Technologies Target Price Odds to finish over Current Price
The tendency of Theralase OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.22 | 90 days | 0.22 | under 4 |
Based on a normal probability distribution, the odds of Theralase Technologies to move above the current price in 90 days from now is under 4 (This Theralase Technologies probability density function shows the probability of Theralase OTC Stock to fall within a particular range of prices over 90 days) .
Theralase Technologies Price Density |
| Price |
Predictive Modules for Theralase Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Theralase Technologies. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Theralase Technologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Theralase Technologies is not an exception. The market had few large corrections towards the Theralase Technologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Theralase Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Theralase Technologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.97 | |
β | Beta against Dow Jones | 0.55 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | 0.13 |
Theralase Technologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Theralase Technologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Theralase Technologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Theralase Technologies is way too risky over 90 days horizon | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| Theralase Technologies appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 780.64 K. Net Loss for the year was (4.41 M) with profit before overhead, payroll, taxes, and interest of 278.88 K. | |
| Theralase Technologies has accumulated about 1.46 M in cash with (4.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Theralase Technologies Fundamentals Growth
Theralase OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Theralase Technologies, and Theralase Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Theralase OTC Stock performance.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | (5.50) % | |||
| Current Valuation | 51.77 M | |||
| Shares Outstanding | 216.5 M | |||
| Price To Earning | (9.16) X | |||
| Price To Book | 20.01 X | |||
| Price To Sales | 52.92 X | |||
| Revenue | 780.64 K | |||
| EBITDA | (4.13 M) | |||
| Cash And Equivalents | 1.46 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 494.32 K | |||
| Debt To Equity | 0.19 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (4.03 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 5.94 M | |||
About Theralase Technologies Performance
By analyzing Theralase Technologies' fundamental ratios, stakeholders can gain valuable insights into Theralase Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Theralase Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Theralase Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada. Theralase Technologi operates under Medical Devices classification in the United States and is traded on OTC Exchange.Things to note about Theralase Technologies performance evaluation
Checking the ongoing alerts about Theralase Technologies for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Theralase Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Theralase Technologies is way too risky over 90 days horizon | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| Theralase Technologies appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 780.64 K. Net Loss for the year was (4.41 M) with profit before overhead, payroll, taxes, and interest of 278.88 K. | |
| Theralase Technologies has accumulated about 1.46 M in cash with (4.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Theralase Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Theralase Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Theralase Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Theralase Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Theralase Technologies' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Theralase Technologies' otc stock. These opinions can provide insight into Theralase Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Theralase OTC Stock analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |